Galaxa Pharma a/s: Financial statements 2025
CVR: 41183144
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
Galaxa Pharma a/s (CVR 41183144) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -398,874 and a net result of DKK -461,281 compared with DKK -819,815 the year before. Equity in the 2025 report amounted to DKK -209,574. The company had 1 employee in the financial year.
- Gross Profit
- DKK -398,874
- Profit/Loss
- DKK -461,281
- Equity
- DKK -209,574
- Total Assets
- DKK 1,402,477
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -399K | -461K | -210K | 1 |
| 2024 | - | -898K | -820K | 252K | 1 |
| 2023 | - | -2M | -1.7M | 572K | 1 |
| 2022 | - | -846K | -2M | 814K | 2 |
| 2021 | 666K | -6K | -134K | 360K | 1 |
Official annual report
How creditworthy is Galaxa Pharma a/s?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of April 10, 2025, Mads Verner Jørgensen has left the board of directors of Galaxa Pharma a/s.
Galaxa Pharma a/s has published its annual report for 2024. Gross profit came to DKK -898,059, and the net result was DKK -819,815.
As of March 28, 2025, Mads Verner Jørgensen has joined the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Lone Henriksen has joined the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Ib Madsen has left the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Flemming Heegaard has left the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Anders Permin has left the board of directors of Galaxa Pharma a/s.
As of March 28, 2025, Jesper Herold Halle has left the board of directors of Galaxa Pharma a/s.
About Galaxa Pharma a/s
Galaxa Pharma a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named CanNordic A/S. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -398,874 and a net result of DKK -461,281 compared with DKK -819,815 the year before. Equity in the 2025 report amounted to DKK -209,574.